Your browser doesn't support javascript.
loading
Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Kono, Masato; Nakamura, Yutaro; Enomoto, Noriyuki; Saito, Go; Koyanagi, Yu; Miyashita, Koichi; Tsutsumi, Akari; Kobayashi, Takeshi; Yasui, Hideki; Hozumi, Hironao; Karayama, Masato; Suzuki, Yuzo; Furuhashi, Kazuki; Miki, Yoshihiro; Hashimoto, Dai; Fujisawa, Tomoyuki; Inui, Naoki; Suda, Takafumi; Nakamura, Hidenori.
  • Kono M; Seirei Hamamatsu General Hospital, Department of Pulmonary Medicine, Japan.
  • Nakamura Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan. Electronic address: nakayuta@hama-med.ac.jp.
  • Enomoto N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Saito G; Seirei Hamamatsu General Hospital, Department of Pulmonary Medicine, Japan.
  • Koyanagi Y; Seirei Hamamatsu General Hospital, Department of Pulmonary Medicine, Japan.
  • Miyashita K; Seirei Hamamatsu General Hospital, Department of Pulmonary Medicine, Japan.
  • Tsutsumi A; Seirei Hamamatsu General Hospital, Department of Pulmonary Medicine, Japan.
  • Kobayashi T; Seirei Hamamatsu General Hospital, Department of Pulmonary Medicine, Japan.
  • Yasui H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Hozumi H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Karayama M; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Suzuki Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Furuhashi K; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Miki Y; Seirei Hamamatsu General Hospital, Department of Pulmonary Medicine, Japan.
  • Hashimoto D; Seirei Hamamatsu General Hospital, Department of Pulmonary Medicine, Japan.
  • Fujisawa T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Inui N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Suda T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Nakamura H; Seirei Hamamatsu General Hospital, Department of Pulmonary Medicine, Japan.
Respir Investig ; 57(6): 552-560, 2019 Nov.
Article en En | MEDLINE | ID: mdl-31477470
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridonas / Capacidad Vital / Fibrosis Pulmonar Idiopática Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridonas / Capacidad Vital / Fibrosis Pulmonar Idiopática Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article